BIO-key Reports Q4 Loss of 19 Cents Per Share, Significantly Missing Estimates
Summary
BIO-key International, Inc. announced a fourth-quarter loss of 19 cents per share. This result is significantly worse than the analyst consensus, which anticipated a loss of 7 cents per share for the same period, as noted in a Reuters report just days ago. The substantial earnings miss indicates a weaker financial performance than expected and is a material negative development for the company, especially given its small market capitalization. Traders will be closely watching for further details from the company regarding the factors contributing to this increased loss and any updated outlook.
At the time of this announcement, BKYI was trading at $0.59 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.51 to $1.97. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.